OM, developed to provide immunity against the Omicron variant of Covid-19, has received approval from the regulator Drug ...

A research team in Korea has developed a vaccine technology that delivers long-lasting immune protection from a single dose ...

A sweeping global review led by researchers at the University of British Columbia has found that mRNA vaccines—now ...

The RNA technology used widely during the pandemic is already being adapted to fight the flu, RSV — and even for personalized ...

The COVID-19 vaccine was a triumph of science. Governments, researchers, and vaccine manufacturers worked in tandem to ...

A drug commonly used to treat epilepsy could be repurposed to significantly boost the response to vaccines in humans, helping protect those for whom the vaccine is less effective, such as older adults ...

Researchers developed a mussel-inspired adhesive adjuvant that anchors antigens and prolongs release. It enhanced T-cell ...

A review of data covering billions of doses of mRNA vaccines has found "compelling" evidence that the technology is both safe ...

AI has been used to develop a universal vaccine that could protect against multiple coronaviruses. The successful Phase 1 ...

When Pfizer Inc. and BioNTech SE’s Covid-19 vaccine rolls off production lines, Shanghai Fosun Pharmaceutical Group Co. will be waiting to distribute it through a complex and costly system of ...

How closely have you been following events in Japan? Try The Mainichi News Quiz for June 30 to test your news knowledge.